跳至主要内容
临床试验/NCT06385756
NCT06385756尚未招募4 期

Effect of Amobarbital Sodium Combined With Low-dose Propofol on Hemodynamics During Induction and Perioperative Adverse Reactions in Gynecological Laparoscopic Surgery

Tongji Hospital0 个研究点目标入组 96 人开始时间: 2024年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
96
主要终点
Mean arterial pressure (MAP) during Induction of anesthesia

研究概览

简要总结

At present, there are limited data on perioperative efficacy of barbiturates at home and abroad. The purpose of this clinical trial is to observe the effects of amobarbital sodium combined with low-dose propofol on hemodynamics during induction and perioperative adverse reactions in gynecological laparoscopic surgery patients, and to provide a more reasonable, safe and comfortable anesthesia program for female patients who undergoing laparoscopic surgery.

The main questions it aims to answer are:

  • whether the combination of the two results on more stable hemodynamics during induction in gynecological laparoscopic surgery patients;
  • whether the incidence of perioperative oxidative stress and inflammation and postoperative nausea and vomiting(ponv) improved after the use of the two combinations of anesthesia induction.

Participants will:

  • Induction of anesthesia with the experimental drug or placebo;
  • 5 ml of venous blood was retained before, after, and 1 day after surgery for follow-up determination of serum associated factor levels;
  • To record their vital signs at any point during the anaesthetic process; Serum serological indexes related to oxidative stress and inflammation were determined. The agitation during the recovery period was recorded. The incidence and severity of ponv were recorded at 2h, 2-6h, and 6-24h postoperatively, and the use of palonosetron was also recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 40~60 years old;
  • ASA Class I to II;
  • The operation time was 1h~2h;
  • BMI 18~25;
  • Sign informed consent.

排除标准

  • Known allergy to narcotic drugs used in this study;
  • Severe pulmonary insufficiency;
  • Abnormal liver and kidney function;
  • History of severe anemia and hematoporphyrin;
  • History of asthma;
  • Uncontrolled high blood pressure or diabetes;
  • Pregnant and lactating women;
  • Accompanied by cognitive impairment or inability to communicate.

研究组 & 干预措施

amobarbital-propofol group

Experimental

Participants were given amobarbital sodium 1 mg/kg 1 min before induction and propofol 1.5mg /kg following.

干预措施: Amobarbital (Drug)

amobarbital-propofol group

Experimental

Participants were given amobarbital sodium 1 mg/kg 1 min before induction and propofol 1.5mg /kg following.

干预措施: Propofol (Drug)

propofol group

Placebo Comparator

The propofol group was given the same volume of normal saline 1 min before induction, followed by propofol 2.5mg /kg.

干预措施: Propofol (Drug)

结局指标

主要结局

Mean arterial pressure (MAP) during Induction of anesthesia

时间窗: Up to 3 hours

MAP was recorded as the main index of hemodynamics during anesthesia induction

次要结局

  • MAP at different time points(Up to 3 hours)
  • Incidence of postoperative nausea and vomiting (ponv)(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xuebi Tian

Clinical Professor

Tongji Hospital

相似试验